SMTL ID : 7woq.1

The state 1 of Omicron Spike with bispecific antibody FD01

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-1-mer

Ligands

28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain A: N.277, E.278, N.279 Chain B: K.555 Ligand excluded by PLIP NAG.2: 3 residues within 4Å: Chain A: N.328, Q.577, L.579 Ligand excluded by PLIP NAG.3: 2 residues within 4Å: Chain A: N.613, Q.641 Ligand excluded by PLIP NAG.4: 3 residues within 4Å: Chain A: S.705, N.706 Chain C: Y.793 Ligand excluded by PLIP NAG.5: 3 residues within 4Å: Chain A: N.714, Q.923, Q.1068 Ligand excluded by PLIP NAG.6: 3 residues within 4Å: Chain A: N.798, S.800, Q.801 Ligand excluded by PLIP NAG.7: 4 residues within 4Å: Chain A: N.1095, T.1097, H.1098, F.1100 Ligand excluded by PLIP NAG.8: 3 residues within 4Å: Chain A: I.1129, V.1130, N.1131 Ligand excluded by PLIP NAG.9: 2 residues within 4Å: Chain A: Y.28, N.61 Ligand excluded by PLIP NAG.10: 2 residues within 4Å: Chain B: Y.28, N.61 Ligand excluded by PLIP NAG.11: 2 residues within 4Å: Chain B: N.231, T.233 Ligand excluded by PLIP NAG.12: 4 residues within 4Å: Chain B: N.277, E.278, N.279 Chain C: K.555 Ligand excluded by PLIP NAG.13: 4 residues within 4Å: Chain B: N.328, P.576, Q.577, T.578 Ligand excluded by PLIP NAG.14: 5 residues within 4Å: Chain B: N.714, F.715, L.919, Q.923, Q.1068 Ligand excluded by PLIP NAG.15: 2 residues within 4Å: Chain B: N.798, S.800 Ligand excluded by PLIP NAG.16: 4 residues within 4Å: Chain B: A.703, E.1069, K.1070, N.1071 Ligand excluded by PLIP NAG.17: 4 residues within 4Å: Chain B: N.1095, T.1097, H.1098, F.1100 Ligand excluded by PLIP NAG.18: 3 residues within 4Å: Chain B: I.1129, V.1130, N.1131 Ligand excluded by PLIP NAG.19: 3 residues within 4Å: Chain A: I.791, Y.793 Chain B: N.706 Ligand excluded by PLIP NAG.20: 3 residues within 4Å: Chain C: T.106, N.231, T.233 Ligand excluded by PLIP NAG.21: 3 residues within 4Å: Chain C: N.277, E.278, N.279 Ligand excluded by PLIP NAG.22: 5 residues within 4Å: Chain C: N.328, P.576, Q.577, T.578, L.579 Ligand excluded by PLIP NAG.23: 2 residues within 4Å: Chain C: N.613, Q.641 Ligand excluded by PLIP NAG.24: 3 residues within 4Å: Chain B: I.791, Y.793 Chain C: N.706 Ligand excluded by PLIP NAG.25: 4 residues within 4Å: Chain C: T.713, N.714, L.919, Q.923 Ligand excluded by PLIP NAG.26: 2 residues within 4Å: Chain C: N.798, S.800 Ligand excluded by PLIP NAG.27: 4 residues within 4Å: Chain C: N.1095, T.1097, H.1098, F.1100 Ligand excluded by PLIP NAG.28: 1 residues within 4Å: Chain C: N.1131 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, Y. et al., Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies. Cell Discov (2022)

Release Date

2022-11-30

Peptides

Spike glycoprotein: ABC
16L9 Fv: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Spike glycoprotein

16L9 Fv

Related Entries With Identical Sequence